Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Nasuh C Buyukkaramikli, Hedwig M Blommestein, Rob Riemsma, Nigel Armstrong, Fiona J Clay, Janine Ross, Gill Worthy, Johan Severens, Jos Kleijnen, Maiwenn J Al
PharmacoEconomics | ADIS INT LTD | Published : 2017
Awarded by National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Program
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Program (project number 14/177/03 STA) [see the HTA program website for further information-http://www.hta.ac.uk]. This summary of the ERG report was compiled after the AC's review. The views and opinions expressed are the authors' and do not necessarily reflect those of the HTA Programme, NICE, NIHR, NHS, or the Department of Health.